Clinical Trials Logo

Neuropathic Back Pain clinical trials

View clinical trials related to Neuropathic Back Pain.

Filter by:
  • None
  • Page 1

NCT ID: NCT02736890 Terminated - Spinal Cord Injury Clinical Trials

Injecting Botulinum Toxin A Underneath the Skin to Treat Spinal Cord Pain in Patients With Spinal Cord Injury

Start date: March 2016
Phase: Phase 2
Study type: Interventional

Back pain is a common secondary condition of both acute and chronic spinal cord injury (SCI). Current existing treatment including both pharmacologic and non-pharmacologic are limited by marginal efficacy or intolerable side effects. The purpose of this study is to evaluate the potential of subcutaneous injections of botulinum toxin A to provide pain relief in spinal cord injury patients with back pain near the level of injury in the spine. Botulinum toxin A has been shown in both pre-clinical and clinical studies to help with nerve pain. The researchers propose a double blinded placebo controlled crossover study to study the effects of subcutaneous botulinum injections to at--level SCI back pain in patients with spinal cord injury.